カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

はしか・おたふく風邪・風疹ウイルスワクチンの世界市場2022：こども用、大人用

■ 英語タイトル：Global Measles, Mumps, and Rubella Virus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3854）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3854
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：98
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[はしか・おたふく風邪・風疹ウイルスワクチンの世界市場2022：こども用、大人用]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界のはしか・おたふく風邪・風疹ウイルスワクチン市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界のはしか・おたふく風邪・風疹ウイルスワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

はしか・おたふく風邪・風疹ウイルスワクチン市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・こども用、大人用

アプリケーション別セグメントは次のように区分されます。
・公立、私立

世界のはしか・おたふく風邪・風疹ウイルスワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Merck、Tiantan Bio、Minhai Bio、Lanzhou Institute、Beijing Bio-Institute

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、はしか・おたふく風邪・風疹ウイルスワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なはしか・おたふく風邪・風疹ウイルスワクチンメーカーの企業概要、2019年～2022年までのはしか・おたふく風邪・風疹ウイルスワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なはしか・おたふく風邪・風疹ウイルスワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別はしか・おたふく風邪・風疹ウイルスワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのはしか・おたふく風邪・風疹ウイルスワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのはしか・おたふく風邪・風疹ウイルスワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびはしか・おたふく風邪・風疹ウイルスワクチンの産業チェーンを掲載しています。
・第13、14、15章では、はしか・おたふく風邪・風疹ウイルスワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– はしか・おたふく風邪・風疹ウイルスワクチンの概要
– 種類別分析（2017年vs2021年vs2028年）：こども用、大人用
– 用途別分析（2017年vs2021年vs2028年）：公立、私立
– 世界のはしか・おたふく風邪・風疹ウイルスワクチン市場規模・予測
– 世界のはしか・おたふく風邪・風疹ウイルスワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck、Tiantan Bio、Minhai Bio、Lanzhou Institute、Beijing Bio-Institute
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：こども用、大人用
・用途別分析2017年-2028年：公立、私立
・はしか・おたふく風邪・風疹ウイルスワクチンの北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・はしか・おたふく風邪・風疹ウイルスワクチンのヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・はしか・おたふく風邪・風疹ウイルスワクチンのアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・はしか・おたふく風邪・風疹ウイルスワクチンの南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・はしか・おたふく風邪・風疹ウイルスワクチンの中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Measles, Mumps, and Rubella Virus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Child
1.2.3 Adult
1.3 Market Analysis by Application
1.3.1 Overview: Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Public
1.3.3 Private
1.4 Global Measles, Mumps, and Rubella Virus Vaccine Market Size & Forecast
1.4.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales in Volume (2017-2028)
1.4.3 Global Measles, Mumps, and Rubella Virus Vaccine Price (2017-2028)
1.5 Global Measles, Mumps, and Rubella Virus Vaccine Production Capacity Analysis
1.5.1 Global Measles, Mumps, and Rubella Virus Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Measles, Mumps, and Rubella Virus Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Measles, Mumps, and Rubella Virus Vaccine Market Drivers
1.6.2 Measles, Mumps, and Rubella Virus Vaccine Market Restraints
1.6.3 Measles, Mumps, and Rubella Virus Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Measles, Mumps, and Rubella Virus Vaccine Product and Services
2.1.4 Merck Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Tiantan Bio
2.2.1 Tiantan Bio Details
2.2.2 Tiantan Bio Major Business
2.2.3 Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Product and Services
2.2.4 Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Minhai Bio
2.3.1 Minhai Bio Details
2.3.2 Minhai Bio Major Business
2.3.3 Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Product and Services
2.3.4 Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lanzhou Institute
2.4.1 Lanzhou Institute Details
2.4.2 Lanzhou Institute Major Business
2.4.3 Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Product and Services
2.4.4 Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Beijing Bio-Institute
2.5.1 Beijing Bio-Institute Details
2.5.2 Beijing Bio-Institute Major Business
2.5.3 Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Product and Services
2.5.4 Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Measles, Mumps, and Rubella Virus Vaccine Breakdown Data by Manufacturer
3.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Measles, Mumps, and Rubella Virus Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Measles, Mumps, and Rubella Virus Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Measles, Mumps, and Rubella Virus Vaccine Manufacturer Market Share in 2021
3.5 Global Measles, Mumps, and Rubella Virus Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Measles, Mumps, and Rubella Virus Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Measles, Mumps, and Rubella Virus Vaccine Market Size by Region
4.1.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Region (2017-2028)
4.2 North America Measles, Mumps, and Rubella Virus Vaccine Revenue (2017-2028)
4.3 Europe Measles, Mumps, and Rubella Virus Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Revenue (2017-2028)
4.5 South America Measles, Mumps, and Rubella Virus Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Type (2017-2028)
5.3 Global Measles, Mumps, and Rubella Virus Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Application (2017-2028)
6.3 Global Measles, Mumps, and Rubella Virus Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2028)
7.2 North America Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2028)
7.3 North America Measles, Mumps, and Rubella Virus Vaccine Market Size by Country
7.3.1 North America Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Measles, Mumps, and Rubella Virus Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2028)
8.2 Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2028)
8.3 Europe Measles, Mumps, and Rubella Virus Vaccine Market Size by Country
8.3.1 Europe Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Measles, Mumps, and Rubella Virus Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Market Size by Region
9.3.1 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2028)
10.2 South America Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2028)
10.3 South America Measles, Mumps, and Rubella Virus Vaccine Market Size by Country
10.3.1 South America Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Measles, Mumps, and Rubella Virus Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Market Size by Country
11.3.1 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Measles, Mumps, and Rubella Virus Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Measles, Mumps, and Rubella Virus Vaccine
12.3 Measles, Mumps, and Rubella Virus Vaccine Production Process
12.4 Measles, Mumps, and Rubella Virus Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Measles, Mumps, and Rubella Virus Vaccine Typical Distributors
13.3 Measles, Mumps, and Rubella Virus Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Measles, Mumps, and Rubella Virus Vaccine Product and Services
Table 6. Merck Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 8. Tiantan Bio Major Business
Table 9. Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Product and Services
Table 10. Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Minhai Bio Basic Information, Manufacturing Base and Competitors
Table 12. Minhai Bio Major Business
Table 13. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Product and Services
Table 14. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 16. Lanzhou Institute Major Business
Table 17. Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Product and Services
Table 18. Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Beijing Bio-Institute Basic Information, Manufacturing Base and Competitors
Table 20. Beijing Bio-Institute Major Business
Table 21. Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Product and Services
Table 22. Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Measles, Mumps, and Rubella Virus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Measles, Mumps, and Rubella Virus Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Measles, Mumps, and Rubella Virus Vaccine Production Site of Key Manufacturer
Table 28. Measles, Mumps, and Rubella Virus Vaccine New Entrant and Capacity Expansion Plans
Table 29. Measles, Mumps, and Rubella Virus Vaccine Mergers & Acquisitions in the Past Five Years
Table 30. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2017-2022) & (K Units)
Table 31. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2023-2028) & (K Units)
Table 32. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 35. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 36. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Measles, Mumps, and Rubella Virus Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Measles, Mumps, and Rubella Virus Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 40. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 41. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 42. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Measles, Mumps, and Rubella Virus Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Measles, Mumps, and Rubella Virus Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 46. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 47. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2023-2028) & (K Units)
Table 48. North America Measles, Mumps, and Rubella Virus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Measles, Mumps, and Rubella Virus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 55. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2023-2028) & (K Units)
Table 56. Europe Measles, Mumps, and Rubella Virus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Measles, Mumps, and Rubella Virus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 59. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 60. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 61. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. South America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 71. South America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2023-2028) & (K Units)
Table 72. South America Measles, Mumps, and Rubella Virus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Measles, Mumps, and Rubella Virus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 75. South America Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 76. South America Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. South America Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 86. Measles, Mumps, and Rubella Virus Vaccine Raw Material
Table 87. Key Manufacturers of Measles, Mumps, and Rubella Virus Vaccine Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Measles, Mumps, and Rubella Virus Vaccine Typical Distributors
Table 91. Measles, Mumps, and Rubella Virus Vaccine Typical Customers
List of Figures
Figure 1. Measles, Mumps, and Rubella Virus Vaccine Picture
Figure 2. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Type in 2021
Figure 3. Child
Figure 4. Adult
Figure 5. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Application in 2021
Figure 6. Public
Figure 7. Private
Figure 8. Global Measles, Mumps, and Rubella Virus Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Measles, Mumps, and Rubella Virus Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Measles, Mumps, and Rubella Virus Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global Measles, Mumps, and Rubella Virus Vaccine Price (2017-2028) & (USD/Unit)
Figure 12. Global Measles, Mumps, and Rubella Virus Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Measles, Mumps, and Rubella Virus Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Measles, Mumps, and Rubella Virus Vaccine Market Drivers
Figure 15. Measles, Mumps, and Rubella Virus Vaccine Market Restraints
Figure 16. Measles, Mumps, and Rubella Virus Vaccine Market Trends
Figure 17. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Measles, Mumps, and Rubella Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Measles, Mumps, and Rubella Virus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Measles, Mumps, and Rubella Virus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Measles, Mumps, and Rubella Virus Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Measles, Mumps, and Rubella Virus Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Measles, Mumps, and Rubella Virus Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Measles, Mumps, and Rubella Virus Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Measles, Mumps, and Rubella Virus Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Measles, Mumps, and Rubella Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Measles, Mumps, and Rubella Virus Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Measles, Mumps, and Rubella Virus Vaccine
Figure 77. Measles, Mumps, and Rubella Virus Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 麻疹・おたふく風邪・風疹ウイルスワクチンのグローバル市場展望 2023年-2029年：子供、大人
  • 世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 麻疹ワクチンのグローバル市場展望 2023年-2029年：おたふく風邪・麻疹・風疹生ワクチン（MMR-II）、おたふく風邪・麻疹・風疹・水痘ウイルスワクチン（Proquad）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3854 )"はしか・おたふく風邪・風疹ウイルスワクチンの世界市場2022：こども用、大人用" (英文：Global Measles, Mumps, and Rubella Virus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。